[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence].

Source:http://linkedlifedata.com/resource/pubmed/id/8098878

Schweiz Med Wochenschr 1993 May 8 123 18 932-40

Download in:

View as

General Info

PMID
8098878